Business Context and Reporting Period
Company: Oramed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 2, 2008
Reporting Period: Single event date (November 2, 2008)
This filing reports the entry into a material definitive agreement. It does not cover a standard financial reporting period (e.g., quarterly or annual) and contains no operational business updates beyond the legal agreement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is strictly a disclosure of a corporate governance agreement and does not include financial statements or performance metrics.
Material Changes
Item 1.01 - Entry into a Material Definitive Agreement:
- On November 2, 2008, the Company entered into indemnification agreements with each of its directors and executive officers.
- The Company agreed to indemnify these individuals for liabilities incurred due to their service as directors or officers, to the maximum extent permitted by law.
- The agreement form is attached as Exhibit 10.1.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future performance, specific risks, contingencies, or unusual items. The document is limited to the disclosure of the indemnification agreements.
Investor Verification Checklist
- Verify the specific terms and limitations of the indemnification agreements in Exhibit 10.1.
- Confirm the list of directors and executive officers covered by these new agreements.
- Review the Company's most recent 10-Q or 10-K filing for actual financial performance data, as this 8-K contains none.